Literature DB >> 17618075

Presence of mature DC-Lamp+ dendritic cells in sentinel and non-sentinel lymph nodes of breast cancer patients.

A Bembenek1, J Li, C Loddenkemper, W Kemmner, H Stein, K D Wernecke, P M Schlag.   

Abstract

AIM: Our study examined differences in the presence of mature, DC-Lamp+ DC in the SLN and non-SLN according to the extent of metastatic involvement. PATIENTS AND METHODS: Paraffin blocks of the SLN and non-SLN from patients with primary breast cancer who had undergone SLN biopsy and axillary dissection were separated into three groups: (Group A) no tumor cell involvement in the SLN and non-SLN; (Group B) isolated tumor cells or micrometastases in the SLN, and tumor cell-free non-SLN; and (Group C) macrometastases in the SLN. One section of all the SLN and non-SLN was examined with immunohistochemistry using an anti-DC-Lamp-antibody. The densest area occupied by the DC-Lamp+ cells on each slide was quantified and recorded by an electronic imaging system. In this regard, the SLN and non-SLN were compared within the patients of each group using the Wilcoxon signed rank-test (p<0.05).
RESULTS: One hundred and fourteen SLN and 1258 non-SLN from 79 patients were examined. A significantly larger area was occupied by the DC-Lamp(+) cells in the SLN compared to the non-SLN in Groups A (p=0.024) and B (p=0.009), whereas no significant difference was found within Group C (p=0.107).
CONCLUSIONS: This study suggests that the DC-dependent immune response is altered during the process of metastasis formation and is primarily activated before and during formation of micrometastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618075     DOI: 10.1016/j.ejso.2007.05.013

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8+ T cells.

Authors:  Aaron Scott Mansfield; Paivi Heikkila; Karl von Smitten; Jukka Vakkila; Marjut Leidenius
Journal:  Virchows Arch       Date:  2011-09-06       Impact factor: 4.064

2.  Immune cell profile of sentinel lymph nodes in patients with malignant melanoma - FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome.

Authors:  Anita Mohos; Tímea Sebestyén; Gabriella Liszkay; Vanda Plótár; Szabolcs Horváth; István Gaudi; Andrea Ladányi
Journal:  J Transl Med       Date:  2013-02-18       Impact factor: 5.531

Review 3.  Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells?

Authors:  Antigoni Poultsidi; Yiannis Dimopoulos; Ting-Fang He; Triantafyllos Chavakis; Emmanouil Saloustros; Peter P Lee; Constantinos Petrovas
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

4.  Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node.

Authors:  Kim M van Pul; Ronald J C L M Vuylsteke; Rieneke van de Ven; Elisabeth A Te Velde; Emiel J Th Rutgers; Petrousjka M van den Tol; Hein B A C Stockmann; Tanja D de Gruijl
Journal:  J Immunother Cancer       Date:  2019-05-22       Impact factor: 13.751

5.  Presence of Dendritic Cell Subsets in Sentinel Nodes of Breast Cancer Patients Is Related to Nodal Burden.

Authors:  Joanna Szpor; Joanna Streb; Anna Glajcar; Piotr Sadowski; Anna Streb-Smoleń; Robert Jach; Diana Hodorowicz-Zaniewska
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

6.  Development of automated quantification methodologies of immunohistochemical markers to determine patterns of immune response in breast cancer: a retrospective cohort study.

Authors:  Carlos López; Cristina Callau; Ramon Bosch; Anna Korzynska; Joaquín Jaén; Marcial García-Rojo; Gloria Bueno; Ma Teresa Salvadó; Tomás Álvaro; Montse Oños; María del Milagro Fernández-Carrobles; Montserrat Llobera; Jordi Baucells; Guifré Orero; Marylène Lejeune
Journal:  BMJ Open       Date:  2014-08-04       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.